If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email email@example.com.
Please tell us what format you need. It will help us if you say what assistive technology you use.
This document is a response to the 2011 guidance from the National Institute for Health and Care Excellence (NICE) on Interferon Gamma Release Assay tests.